Proceeds will go toward buying back as much as $225 million of stock, the company said in a statement Citigroup inc., jpmorgan chase & co And morgan stanley are managing the offering, the. &dwhjrulhv 3duw 1xpehu 3urgxfw 7\sh &$7 0dwhuldo ,' 3urgxfw ghvfulswlrq 6l]h &xuuhqf\ 3ulfh. Top news and commentary for technology's leaders, from all around the web. Altrubio has roared back after another pivot in its twisty history, securing up to $225 million in series b funding to take an immune checkpoint enhancer through a midphase ulcerative colitis program.
OPEN
